Preferential metabolism of (—)-3H-norepinephrine through the deaminated glycol in the rat vas deferens

[1]  S. Z. Langer,et al.  Pre- and postsynaptic origin of the norepinephrine metabolites formed during transmitter release elicited by nerve stimulation. , 1972, The Journal of pharmacology and experimental therapeutics.

[2]  S. Z. Langer,et al.  Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. , 1972, The Journal of pharmacology and experimental therapeutics.

[3]  H. Yamamoto,et al.  Effects of nerve stimulation on the uptake of norepinephrine by the perfused spleen of the cat. , 1972, European journal of pharmacology.

[4]  S. Z. Langer,et al.  The fate of 3 H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation. , 1971, The Journal of pharmacology and experimental therapeutics.

[5]  F. Stefano,et al.  The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3 H-norepinephrine released from the adrenergic neuron. , 1971, The Journal of pharmacology and experimental therapeutics.

[6]  B. Fredholm,et al.  Fate of 3H-noradrenaline in canine subcutaneous adipose tissue. , 1970, Acta physiologica Scandinavica.

[7]  S. Z. Langer.  The metabolism of [3H]noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat , 1970, The Journal of physiology.

[8]  F. Stefano,et al.  Desipramine-induced release of norepinephrine from heart. , 1970, Biochemical pharmacology.

[9]  L. Iversen,et al.  Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens , 1969, British journal of pharmacology.

[10]  K. Taylor,et al.  THE METABOLISM OF TRITIATED DOPAMINE IN REGIONS OF THE RAT BRAIN IN VIVO—I , 1969, Journal of neurochemistry.

[11]  R. Mueller,et al.  Subcellular localization of monoamine oxidase in rat tissues. , 1969, The Journal of pharmacology and experimental therapeutics.

[12]  K. C. Richardson,et al.  Uptake and metabolism of dl-norepinephrine by subcellular particles of rat heart. , 1968, The Journal of pharmacology and experimental therapeutics.

[13]  E. Costa,et al.  Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration. , 1968, The Journal of pharmacology and experimental therapeutics.

[14]  K. Taylor,et al.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. , 1968, Analytical biochemistry.

[15]  C. Rutledge,et al.  Metabolic pathways of dopamine and norepinephrine in rabbit brain in vitro. , 1967, The Journal of pharmacology and experimental therapeutics.

[16]  N. Weiner,et al.  The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart. , 1967, The Journal of pharmacology and experimental therapeutics.

[17]  E. Costa,et al.  The influence of monoamine oxidase inhibition on catecholamine synthesis. , 1966, Life sciences.

[18]  D. Harrison,et al.  Studies on the distribution of exogenous norepinephrine in the sympathetic neurotransmitter store. , 1963, The Journal of pharmacology and experimental therapeutics.

[19]  A. Anton,et al.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. , 1962, The Journal of pharmacology and experimental therapeutics.

[20]  I. Kopin,et al.  Metabolism of norepinephrine-H3 released by tyramine and reserpine. , 1962, The Journal of pharmacology and experimental therapeutics.

[21]  L G WHITBY,et al.  The fate of H3-norepinephrine in animals. , 1961, The Journal of pharmacology and experimental therapeutics.

[22]  U. S. Euler,et al.  Improved technique for the fluorimetric estimation of catecholamines. , 1961, Acta physiologica Scandinavica.